Biology subjects

Vincent, R. M.

Publications and source records attributed to Vincent, R. M..

3 recordsLinked to original sources

bioRxiv2025

Defining bottlenecks and physiological impact of an orthogonal translation initiation system

Reengineering translation initiation provides a powerful route to develop new translation systems that enable precise control of protein synthesis. While many engineered translation systems show promise, their orthogonality and impact on host physiology is largely uncharacterized, limiting broader application. Here, we develop an initiator-tRNA with an AAC anticodon mutation (i-tRNA-AAC), enabling translation initiation at a GUU start codon. Using fluorescence assays, proteomics, and tRNA sequencing, we assess the i-tRNA-AAC initiation orthogonality and effects on the host, guiding the optimization of its translational efficiency. We find the i-tRNA-AAC mutant initiates translation exclusively from its GUU start codon and is improved by overexpression of valyl-tRNA synthetase and methionyl-tRNA formyltransferase. However, this intervention perturbs aminoacylation and base modifications of endogenous tRNAs along with proteome-wide changes likely due to increased valine demand. Our findings demonstrate how an orthogonal translation initiation system reshapes host physiology and reveals the adaptive responses that accompany translational reprogramming.

synthetic biology↗

bioRxiv2025

An Expanded Repertoire of tRNA Sources for Cell-Free Protein Synthesis

Cell-free expression systems (CFE) are flexible protein translation platforms that simplify the central dogma into an accessible reaction space. Within these systems, bulk transfer RNAs (tRNAs) are critical substrates which deliver amino acids to the elongating ribosome. For years, CFE systems were completed with commercially available tRNA isolated from E. coli MRE600. All commercial sources of tRNA have since been discontinued, jeopardizing future work in all applications of cell-free translation. Here, we address this need by repurposing previously described tRNA isolation methods to produce tRNAs suitable for CFE applications. We isolated the tRNA pools of E. coli strains A19, BL21(DE3), and Rosetta2 BL21(DE3), finding A19 tRNAs but not BL21(DE3) or Rosetta2 BL21(DE3) capable of robust in vitro translation. We determined the abundances of individual tRNAs using tRNA-seq, finding BL21(DE3) and Rosetta2 BL21(DE3) contained outsized abundances of several tRNAs, compromising translation activity. Using codon optimization strategies which align codon usage to tRNA abundance, we were able to mitigate the impact of misaligned tRNA abundances. We extended these studies to V. natriegens, a promising platform for synthetic biology and CFE. We find that neither exogenous V. natriegens tRNAs nor codon optimization are viable options to improve translation yields. Our work here highlights the importance of tRNA abundance within the context of CFE, and simultaneously addresses a critical challenge within cell-free translation.

biochemistry↗

bioRxiv2019

Measuring amber initiator tRNA orthogonality in a genomically recoded organism

Using engineered initiator tRNA for precise control of protein translation within cells has great promise within future orthogonal translation systems to decouple housekeeping protein metabolism from that of engineered genetic systems. Previously, E. coli strain C321.{Delta}A.exp lacking all UAG stop codons was created, freeing this amber stop codon for other purposes. An engineered amber initiator [Formula] that activates translation at UAG codons is available, but little is known about this tRNAs orthogonality. Here, we combine for the first time the amber initiator [Formula]in C321.{Delta}A.exp and measure its cellular effects. We found that the [Formula]expression resulted in a nearly 200Yfold increase in fluorescent reporter expression with a unimodal population distribution and no apparent cellular fitness defects. Proteomic analysis revealed upregulated ribosomeYassociated, tRNA degradation, and amino acid biosynthetic proteins, with no evidence for offYtarget translation initiation. In contrast to previous work, we show that UAGYinitiated proteins carry NYterminal methionine exclusively. Together, our results identify beneficial features of using the amber initiator [Formula]to control gene expression while also revealing fundamental challenges to using engineered initiator tRNAs as the basis for orthogonal translation initiation systems.

synthetic biology↗